Comparison of the treatment effect of percutaneous nephrolithotomy access to pyelocalyceal system through ultrasonography versus fluoroscopy in patients with kidney stone

Comparison of the treatment effect of percutaneous nephrolithotomy access to pyelocalyceal system through ultrasonography versus fluoroscopy in patients with kidney stone: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201704089014N155

Enrollment

Registered

2017-04-10

Start date

2017-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney stone. Calculus of kidney

Interventions

Intervention 1: Intervention group 1: Percutaneous nephrolithotomy through ultrasonography. Intervention 2: Intervention group 2: Percutaneous nephrolithotomy through fluoroscopy.

Treatment - Surgery

Treatment - Drugs

Intervention group 1: Percutaneous nephrolithotomy through ultrasonography.

Intervention group 2: Percutaneous nephrolithotomy through fluoroscopy.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 65 years; having kidney stone. Exclusion criteria: Cardiopulmonary disease; coagulopathy; untreated urinary tract infection; severe obesity with body mass index above35.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Amount of access to pyelocalyceal system. Timepoint: during surgery. Method of measurement: through clinical evaluation.;Duration of time to access to pyelocalyceal system. Timepoint: during surgery. Method of measurement: through clinical evaluation.	—

Secondary

Measure	Time frame
Hydronephrosis. Timepoint: 24 and 48 hours after surgery. Method of measurement: trough physical examination.;Amount of bleeding. Timepoint: during surgery. Method of measurement: through measuring volume of suctioned blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Poya Parsi

Shahid Beheshti Hospital

pouyaparsi6699@gmail.com+98 81 3838 0283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026